Search

Filters

Clear Filters
3:00 PM - 4:00 PM ET

2088 - Rethinking the Limits: SRS for =20 Brain Metastases with Favorable Brain and Hippocampal Doses
Speaker: Ho, Alexander, MD, BS - Northwestern Memorial Hospital, Chicago, IL
3:00 PM - 4:00 PM ET

2089 - Treatment-Related Lymphopenia Predicts Survival in Glioblastoma: Evidence from a Large Cohort Treated with Radiation/TMZ Incorporating Brain Dosimetric Analysis
Speaker: Ho, Alexander, MD, BS - Northwestern Memorial Hospital, Chicago, IL
11:45 AM - 11:55 AM ET

209 - a and ß Emitting Radiopharmaceutical Therapy (RPT) and Total Marrow and Lymphoid Irradiation (TMLI) Conditioning in Relapsed / Refractory (R/R) AML / ALL Undergoing Allogeneic Transplant (alloHCT)
Speaker: Wong, Jeffrey, MD, FASTRO - City of Hope National Medical Center, Duarte, CA
3:00 PM - 4:00 PM ET

2090 - A Single Arm Phase II Study Assessing Efficacy of Stereotactic Radiosurgery (SRS) for Brain Metastasis (BM) from Small Cell Lung Cancer (SCLC)
Speaker: Hockemeyer, Kathryn, MD, PhD - Memorial Sloan Kettering Cancer Center, New York, NY
3:00 PM - 4:00 PM ET

2091 - Longitudinal Outcomes and Toxicity after CNS Stereotactic Radiosurgery in Pediatric and AYA Patients
Speaker: Hokanson, Casey, BA - University of Minnesota, Minneapolis, MN
3:00 PM - 4:00 PM ET

2092 - Selective Benefit of Adjuvant Chemoradiotherapy after Inadequate D2 Dissection in Gastric Cancer: A Multicenter Retrospective Comparative Study
Speaker: Hossain, Altaf, MD, MBBS - Directorate General of Health Service, Khulna, Khulna
9:39 AM - 9:45 AM ET

2093 - Risk Factors of Vertebral Compression Fracture after Spine Stereotactic Radiosurgery for Lung Cancer: Pooled Post Hoc Analysis of Two Phase II Trials
Speaker: Hsu, Feng-Ming, MD, PhD - National Taiwan University Cancer Center, Taipei, Taipei
3:00 PM - 4:00 PM ET

2094 - Evaluation of Single- vs. Dual-Arc Dynamic Collimator VMAT for Stereotactic Spine Radiosurgery Using a Modified Modulation Complexity Metric
Speaker: Hsu, Feng-Ming, MD, PhD - National Taiwan University Cancer Center, Taipei, Taipei
3:00 PM - 4:00 PM ET

2095 - Comparative Effectiveness of Intensity-Modulated Proton Therapy (IMPT), Passive-Scattering Proton Therapy (PSPT), and Volumetric-Modulated Arc Therapy (VMAT) on Radiation-Induced Lymphopenia (RIL) in Esophageal Cancer (EC) Chemoradiotherapy
Speaker: Hu, Zongsheng, MS - MD Anderson Cancer Center, Houston, TX
3:00 PM - 4:00 PM ET

2096 - Weight Loss during Neoadjuvant Chemoradiotherapy Predicts Survival after Esophagectomy for Locally Advanced Esophageal Squamous Cell Carcinoma
Speaker: Huang, Guiyu, MD - Cancer Hospital affiliate to University of Electronic Science and Technology, Chengdu
3:00 PM - 4:00 PM ET

2097 - Novel Insights into Cell Death Pathways in Esophageal Cancer Radiotherapy: A Strategic Framework Highlighting HMGB1 as Dual Prognostic Biomarker and Therapeutic Target
Speaker: Huang, Wei, MD, PhD - Shandong Cancer Hospital, Jinan, Shandong
3:00 PM - 4:00 PM ET

2098 - Spine SBRT for Non-Invasive Decompression: Epidural Tumour Dynamics Following 2-Fraction Spine SBRT
Speaker: Hughes, Alec, MD, PhD - University of Toronto